CompletedNot Applicable

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

United States354 participantsStarted 2023-08-29

Plain-language summary

The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * GLP 1 patient group: any patient on GLP1 agonists that are dosed once per week (semaglutide, dulaglutide, tirzepatide), for all indications. * Control group (No GLP 1 patients): any patient not on GLP1 agonists that are dosed once per week, for all indications. Exclusion Criteria: * patient refusal to participate * patients with gastric bypass or any other gastric surgery * large hiatal hernia * patients with large ascites * patients on peritoneal dialysis * emergency surgery * pre-existing diagnosis of gastroparesis

What they're measuring

incidence of delayed gastric emptying

Timeframe: This will be measured pre-operatively in the holding room area.

Trial details

NCT IDNCT06003985

SponsorHospital for Special Surgery, New York

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Gastric Ultrasound trials